Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
May 12, 2021

Medical Devices industry M&A deals total $26.81bn in North America in Q1 2021

Total medical devices industry M&A deals worth $26.81bn were announced in North America in Q1 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 124.5% over the previous quarter and a rise of 70.9% when compared with the last four-quarter average of $15.69bn.

North America held an 87.33% share of the global medical devices industry M&A deal value that totalled $30.7bn in Q1 2021. With an 86.74% share and deals worth $26.63bn, the US was the top country in North America’s M&A deal value across medical devices industry.

In terms of deal activity, North America recorded 94 deals during Q1 2021, marking an increase of 30.56% over the previous quarter and a rise of 47.45% over the last four-quarter average. The US recorded 85 deals during the quarter.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

North America medical devices industry M&A deals in Q1 2021: Top deals

The top five medical devices industry M&A deals accounted for 76.2% of the overall value during Q1 2021.

The combined value of the top five M&A deals stood at $20.42bn, against the overall value of $26.81bn recorded for the quarter.

The top five medical devices industry deals of Q1 2021 tracked by GlobalData were:

1) OptumInsight’s $13bn acquisition of Change Healthcare

2) The $4.6bn acquisition of Cantel Medical by Steris

3) Boston Scientific’s $1.23bn acquisition of 78% stake in Preventice

4) The $800m acquisition of Surgical Specialties by Corza Health

5) The merger of CM Life Sciences and Mount Sinai Genomics for $793m.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy